Chapman JS - Search Results

1

Discovering dominant tumor immune archetypes in a pan-cancer census.

Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB; Immunoprofiler Consortium; Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. Combes AJ, et al. Among authors: chapman js. Cell. 2022 Jan 6;185(1):184-203.e19. doi: 10.1016/j.cell.2021.12.004. Epub 2021 Dec 27. Cell. 2022. PMID: 34963056 Free PMC article.

2

Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.

Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek CJ, Ueda S, Collisson EA, Taylor BS. Chapman JS, et al. J Natl Compr Canc Netw. 2015 Jul;13(7):835-45. doi: 10.6004/jnccn.2015.0101. J Natl Compr Canc Netw. 2015. PMID: 26150578

3

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.

Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. Chang MT, et al. Among authors: chapman js. Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30. Nat Biotechnol. 2016. PMID: 26619011 Free PMC article.

4

Re: "Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course".

Klauschen F, Bläker H, Stenzinger A, Chapman JS, Collisson EA, Taylor BS. Klauschen F, et al. Among authors: chapman js. J Natl Compr Canc Netw. 2016 Mar;14(3):lxvi-lxviii. doi: 10.6004/jnccn.2016.0040. J Natl Compr Canc Netw. 2016. PMID: 26957621 No abstract available.

5

The Authors Respond.

Chapman JS, Collisson EA, Taylor BS. Chapman JS, et al. J Natl Compr Canc Netw. 2016 Mar;14(3):lxviii. J Natl Compr Canc Netw. 2016. PMID: 27396027 No abstract available.

6

Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications.

Chapman JS, Roddy E, Westhoff G, Simons E, Brooks R, Ueda S, Chen L. Chapman JS, et al. Gynecol Oncol. 2015 Jun;137(3):523-8. doi: 10.1016/j.ygyno.2015.04.003. Epub 2015 Apr 16. Gynecol Oncol. 2015. PMID: 25888979

7

Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.

Guix I, Liu Q, Pujana MA, Ha P, Piulats J, Linares I, Guedea F, Mao JH, Lazar A, Chapman J, Yom SS, Ashworth A, Barcellos-Hoff MH. Guix I, et al. Clin Cancer Res. 2022 Apr 1;28(7):1372-1382. doi: 10.1158/1078-0432.CCR-21-2846. Clin Cancer Res. 2022. PMID: 35022323 Free PMC article.

8

Genomic insights in gynecologic cancer.

Roddy E, Chapman J. Roddy E, et al. Curr Probl Cancer. 2017 Jan-Feb;41(1):8-36. doi: 10.1016/j.currproblcancer.2016.11.001. Epub 2016 Nov 11. Curr Probl Cancer. 2017. PMID: 28088330 Review.

9

Inflammatory Myofibroblastic Tumor Associated With the Placenta: Short Tandem Repeat Genotyping Confirms Uterine Site of Origin.

Ladwig NR, Schoolmeester JK, Weil L, Chapman JS, Zaloudek C, Umetsu SE. Ladwig NR, et al. Among authors: chapman js. Am J Surg Pathol. 2018 Jun;42(6):807-812. doi: 10.1097/PAS.0000000000001044. Am J Surg Pathol. 2018. PMID: 29505427

10

An integrated molecular profile of endometrioid ovarian cancer.

Pierson WE, Peters PN, Chang MT, Chen LM, Quigley DA, Ashworth A, Chapman JS. Pierson WE, et al. Among authors: chapman js. Gynecol Oncol. 2020 Apr;157(1):55-61. doi: 10.1016/j.ygyno.2020.02.011. Epub 2020 Mar 3. Gynecol Oncol. 2020. PMID: 32139151 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page